Invariant NKT Cells as Initiators, Licensors, and Facilitators of the Adaptive Immune Response
Open Access
- 15 December 2003
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 198 (12) , 1779-1783
- https://doi.org/10.1084/jem.20031946
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer StainingThe Journal of Experimental Medicine, 2002
- A B Cell Superantigen–Induced Persistent “Hole” in the B-1 RepertoireThe Journal of Experimental Medicine, 2000
- NKT cells are phenotypically and functionally diverseEuropean Journal of Immunology, 1999
- Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent CellsScience, 1997
- Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E ProductionScience, 1995
- NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.The Journal of Experimental Medicine, 1995
- Mouse NK1+ T cellsCurrent Opinion in Immunology, 1995
- An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.The Journal of Experimental Medicine, 1994
- CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.The Journal of Experimental Medicine, 1994